Revised CRISS Developed to Improve dcSSc Study Outcome Measures in dcSSc
The performance of 5 core set measure in ACR-CRISS in recent trials was explored, and their ability to discern the active medication group from placebo in patients with diffuse cutaneous systemic sclerosis (dcSSc), was assessed.